Dr. Adrian Aurelio Miro Co , MD
General Practice β’ Florida, PR
155-199 Calle Arizmendi
Florida, PR 00650
This profile restates public CMS/NPPES data; T-MedInfo gives no medical advice — consult a licensed professional, and call 911 for emergencies.
-
Dr. Adrian Miro Co is listed in NPPES under General Practice.
-
NPI assigned on August 20, 2016; this date does not establish years in practice.
-
Published CMS data list 945 Medicare Part D prescriptions, including refills, in 2024.
Source: CMS, Medicare Part D Prescribers β by Provider and Drug, 2024. Published rows only; this is not a quality measure.
-
Published Part D records, 2024:
- Dexamethasone β 119 prescription fills, including refills.
- Atorvastatin Calcium β 105 prescription fills, including refills.
- Sulindac β 83 prescription fills, including refills.
Source: CMS, Medicare Part D Prescribers β by Provider and Drug, 2024. Drug names come from pharmacy claims. Listing a drug here is not an endorsement or a recommendation.
See all 30 records in the table Β· Guide: How to read Medicare Part D prescriber data
-
Close to the middle for Part D prescriptions among clinicians listed under General Practice in Puerto Rico (2024, 2,623 clinicians with data). Median for this group: 1,262. Middle half: 241 to 5,106.
Source: CMS, Medicare Part D Prescribers β by Provider and Drug, 2024. Billing and prescribing volume is not a quality rating.
-
Medicare Part D prescriptions went from 161 in 2022 to 945 in 2024.
Source: CMS, Medicare Part D Prescribers β by Provider and Drug, 2022β2024.
Practice Location & Contact Primary Location
155-199 Calle Arizmendi
Florida, PR 00650
Matched by practice address or phone in NPPES. A shared address or phone does not confirm that this clinician works there.
What Public CMS Data Show
General Practice: NPPES taxonomy is a reported classification, not proof of board certification.
30-day fills
991 standardized 30-day fills in 2024
CMS converts prescriptions to 30-day supplies so they can be compared. A 90-day prescription counts as about three 30-day fills.
What this does not show: 30-day fills
It is not a count of patients and not a measure of quality.
Part D drug cost
$8,185 in 2024
The total cost of these prescriptions in 2024, paid by Medicare drug plans, patients and other payers together.
It shows the total spending on drugs this clinician prescribed, not what any one patient paid.
What this does not show: Part D drug cost
A higher cost often reflects the type of medicines a specialty uses. It is not your out-of-pocket cost and not a measure of quality.
Source: CMS, Medicare Part D Prescribers β by Provider and Drug, 2024.
Open Payments general payments, program year 2025
All general payments: $94.46 across 2 records.
By nature of payment
- Food and Beverage: $94.46 across 2 records.
Reporting-company totals
- GlaxoSmithKline, LLC.: $51.30 across 1 record.
- Sanofi and Genzyme US Companies: $43.16 across 1 record.
A reported payment does not necessarily mean the financial relationship is improper and is not a measure of care quality. Clinicians can review and dispute these records.
Source: Calculated by T-MedInfo from CMS Open Payments general-payment records for program year 2025 (published June 30, 2026).
NPI first issued
2016
The year this clinician's National Provider Identifier (NPI) was issued. An NPI is a unique 10-digit ID that US health care providers use for billing.
What this does not show: NPI first issued
NPIs have been issued only since 2005, so this year is not necessarily when the clinician started practicing.
Source: CMS NPPES NPI Registry.
Medicare assignment not listed
CMS data do not show whether this clinician accepts Medicare assignment. This does not mean they do not accept Medicare. Ask the office.
Medicare assignment applies to Original Medicare. It does not tell you whether the clinician is in a Medicare Advantage plan's network, accepts other insurance, or is taking new patients.
Source: CMS Doctors and Clinicians, CMS release of October 2, 2026; Medicare.gov, βDoes your provider accept Medicare as full payment?β
No telehealth indicator
CMS shows this indicator only when recent Medicare claims include telehealth services. The clinician may still offer telehealth; ask the office.
Source: CMS, Telehealth Indicator on Medicare Care Compare (fact sheet, January 2023); CMS Doctors and Clinicians, CMS release of October 2, 2026.
Compared with the same specialty in Florida and Puerto Rico
Billing and prescribing volume is not a quality rating.
Medicare Part D prescriptions
Close to the middle for clinicians listed under General Practice in Puerto Rico (2024, 2,623 clinicians with data). Median for this group: 1,262. Middle half: 241 to 5,106.
Too few clinicians listed under General Practice in Florida have Medicare Part D data for 2024 to compare.
Part D drug cost
A lower Part D drug cost than 60% of clinicians listed under General Practice in Puerto Rico (2024, 2,623 clinicians with data). Median for this group: $34,550. Middle half: $2,978 to $214,501.
Too few clinicians listed under General Practice in Florida have Medicare Part D data for 2024 to compare.
8 active clinicians are listed under General Practice with a practice address in Florida, PR (4,225 in Puerto Rico).
Addresses are self-reported to NPPES and may be out of date.
CMS data by year
Changes may reflect reporting, coverage or privacy limits, not changes in care quality.
-
Medicare Part D prescriptions
Medicare Part D prescriptions increased 487% from 161 in 2022 to 945 in 2024.
- 2022: 161
- 2023: 1,501
- 2024: 945
-
30-day fills
30-day fills increased 329% from 231 in 2022 to 991 in 2024.
- 2022: 231
- 2023: 2,086
- 2024: 991
-
Part D drug cost
Part D drug cost went from $954 in 2022 to $8,185 in 2024.
- 2022: $954
- 2023: $55,978
- 2024: $8,185
-
Industry payments (Open Payments)
CMS data for industry payments (Open Payments) are available for 2025 only.
Sources: CMS Medicare Part D Prescribers (2024), CMS Open Payments (2025), CMS Doctors and Clinicians, CMS release of October 2, 2026, CMS NPPES NPI Registry. Specialty names follow the NUCC Health Care Provider Taxonomy.
Text: T-MedInfo Β· Report an error.
Pharma & Medical Device Financial Disclosures
Payments and other transfers of value that drug and medical device companies reported to CMS Open Payments
Program year 2025 (payments made January 1 β December 31, 2025): fewer than 11 records totaling $94.46.
| Manufacturer | Payment Nature | Product | Type | Amount ($) |
|---|---|---|---|---|
| GlaxoSmithKline, LLC. |
Food and Beverage
In-kind items and services
|
β | General | $51.30 |
| Sanofi and Genzyme US Companies |
Food and Beverage
In-kind items and services
|
β | General | $43.16 |
Source: CMS Open Payments, program year 2025, released June 30, 2026.
Medicare Part D Prescribing Profile & Medications
Medicare Part D prescriptions filled, including refills, in 2024.
| Brand Name | Generic Name | Prescriptions | Day Supply | Total Cost | Patients |
|---|---|---|---|---|---|
| Dexamethasone | Dexamethasone | 119 | 590 | $893.23 | 110 |
| Atorvastatin Calcium | Atorvastatin Calcium | 105 | 3,494 | $684.43 | 26 |
| Sulindac | Sulindac | 83 | 725 | $697.39 | 75 |
| Montelukast Sodium | Montelukast Sodium | 76 | 1,320 | $320.44 | 57 |
| Omeprazole | Omeprazole | 68 | 1,859 | $360.25 | 26 |
| Gabapentin | Gabapentin | 38 | 1,134 | $212.73 | 13 |
| Orphenadrine Citrate Er | Orphenadrine Citrate | 34 | 270 | $479.66 | 33 |
| Metformin Hcl | Metformin Hcl | 30 | 960 | $83.38 | β |
| Tamsulosin Hcl | Tamsulosin Hcl | 26 | 729 | $145.96 | 13 |
| Lisinopril | Lisinopril | 24 | 960 | $102.56 | β |
| Metoprolol Succinate | Metoprolol Succinate | 24 | 720 | $170.18 | β |
| Hydrochlorothiazide | Hydrochlorothiazide | 22 | 660 | $101.86 | β |
| Fenofibrate | Fenofibrate Nanocrystallized | 22 | 660 | $230.79 | β |
| Clopidogrel | Clopidogrel Bisulfate | 21 | 750 | $163.63 | β |
| Levothyroxine Sodium | Levothyroxine Sodium | 21 | 630 | $151.23 | β |
| Losartan Potassium | Losartan Potassium | 21 | 750 | $151.86 | β |
| Amlodipine Besylate | Amlodipine Besylate | 20 | 660 | $60.19 | β |
| Glimepiride | Glimepiride | 20 | 600 | $206.30 | β |
| Oseltamivir Phosphate | Oseltamivir Phosphate | 18 | 90 | $543.60 | 18 |
| Alendronate Sodium | Alendronate Sodium | 17 | 500 | $81.73 | β |
| Famotidine | Famotidine | 17 | 510 | $96.95 | β |
| Enalapril Maleate | Enalapril Maleate | 16 | 480 | $159.82 | β |
| Pentoxifylline | Pentoxifylline | 15 | 450 | $511.82 | β |
| Topiramate | Topiramate | 14 | 420 | $58.55 | β |
| Losartan-Hydrochlorothiazide | Losartan/Hydrochlorothiazide | 14 | 420 | $131.61 | β |
(top 25 shown)
Source: CMS Part D by Provider and Drug, 2024; rows below 11 claims omitted by CMS; volume isn’t quality. Privacy limits
Specialties & License Numbers Reported to NPPES
Self-certified to NPPES: 2024-02-21NUCC Taxonomy Code: 208D00000X
A physician who specializes in the general practice of diagnosing, treating, and managing patients with a variety of illnesses and conditions.
Career & Practice History Timeline
Changes recorded in monthly NPPES data files: addresses, names, credentials, specialties and NPI status
Registered at 155-199 CALLE ARIZMENDI, FLORIDA, PR 00650 (Tel: 7878222170)
Registered at 100 PR-682 #831, GARROCHALES, ARECIBO, PR 00652
General Practice (license number reported to NPPES: PR 22941)
Recorded as ADRIAN MIRO CO, MD
NPI status registered as active in NPPES database
Registered at 1156 CALLE 62 SE, SAN JUAN, PR 009212724 (Tel: 7877582525)
Registered at PO BOX 800676, COTO LAUREL, PR 007800676
Recorded as ADRIAN MIRO CO
Student in an Organized Health Care Education/Training Program
First registered as active Individual Practitioner in NPPES Database.
NPI Administrative Meta
Other General Practices in Florida
Mailing Address
100 Pr-682 #831, Garrochales
Arecibo, PR 00652